Post-stroke sarcopenia as a neuromuscular disorder: a mini review of neural mechanisms and clinical implications
Abstract
Background: Post-stroke sarcopenia represents a distinct neuromuscular disorder characterized by progressive muscle loss and functional decline. Unlike age-related sarcopenia, stroke-induced muscle wasting involves specific neural mechanisms originating from central nervous system injury.
Objective: To systematically review the neural mechanisms underlying post-stroke sarcopenia and synthesize evidence on its clinical implications, diagnostic approaches, and therapeutic interventions.
Methods: A mini review of the literature was conducted, synthesizing evidence from key studies addressing neural mechanisms, pathophysiology, diagnosis, or treatment of post-stroke sarcopenia.
Results: Post-stroke sarcopenia affects 11%-67% of stroke survivors, with paretic limbs losing >30% muscle mass within 6 months. The pathophysiology involves a cascade from corticospinal tract damage to motor neuron degeneration, neuromuscular junction dysfunction, and muscle fiber atrophy. Key mechanisms include denervation-induced neurogenic atrophy, inflammatory dysregulation (IL-6, TNF-α, myostatin upregulation), and impaired IGF-1/Akt/mTOR signaling. Asymmetric muscle loss patterns distinguish this condition from primary sarcopenia. Diagnostic approaches combine imaging (DXA, BIA, CT), functional assessments (grip strength, gait speed, SPPB), and stroke-specific criteria. Multimodal interventions including neuromuscular electrical stimulation, resistance training, nutritional support, and spasticity…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.